|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/09/17 Organovo Holdings, Inc. 10-Q 6/30/17 44:3.4M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 280K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 21K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
11: R1 Document and Entity Information HTML 37K
12: R2 Condensed Consolidated Balance Sheets HTML 93K
13: R3 Condensed Consolidated Balance Sheets HTML 25K
(Parenthetical)
14: R4 Unaudited Condensed Consolidated Statements of HTML 60K
Operations and Other Comprehensive Loss
15: R5 Unaudited Condensed Consolidated Statements of HTML 77K
Cash Flows
16: R6 Description of Business and Summary of Significant HTML 53K
Accounting Policies
17: R7 Stockholders' Equity HTML 199K
18: R8 Commitments and Contingencies HTML 42K
19: R9 Concentrations HTML 20K
20: R10 Recent Accounting Pronouncements HTML 22K
21: R11 Subsequent Events HTML 19K
22: R12 Description of Business and Summary of Significant HTML 81K
Accounting Policies (Policies)
23: R13 Stockholders' Equity (Tables) HTML 186K
24: R14 Commitments and Contingencies (Tables) HTML 32K
25: R15 Description of Business and Summary of Significant HTML 87K
Accounting Policies - Additional Information
(Detail)
26: R16 Stockholders' Equity - Schedule of Stock-based HTML 24K
Compensation Expense (Detail)
27: R17 Stockholders' Equity - Stock-based Compensation HTML 32K
Expense and Valuation Information - Additional
Information (Detail)
28: R18 Stockholders' Equity - Fair Value of Employee HTML 29K
Stock Options (Detail)
29: R19 Stockholders' Equity - Fair Value of Employee HTML 33K
Stock Purchase Plan (Detail)
30: R20 Stockholders' Equity - Preferred Stock - HTML 20K
Additional Information (Detail)
31: R21 Stockholders' Equity - Common Stock - Additional HTML 109K
Information (Detail)
32: R22 Stockholders' Equity - Restricted Stock Awards and HTML 55K
Restricted Stock Units - Additional Information
(Detail)
33: R23 Stockholders' Equity - Summary of Company's HTML 39K
Restricted Stock Unit Activity (Detail)
34: R24 Stockholders' Equity - Stock Options and Employee HTML 74K
Stock Purchase Plan - Additional Information
(Detail)
35: R25 Stockholders' Equity - Summary of Stock Option HTML 49K
Activity (Detail)
36: R26 Stockholders' Equity - Warrants - Additional HTML 29K
Information (Detail)
37: R27 Stockholders' Equity - Summary of Warrant Activity HTML 41K
(Detail)
38: R28 Stockholders' Equity - Common Stock Reserved for HTML 34K
Future Issuance (Detail)
39: R29 Commitments and Contingencies - Additional HTML 48K
Information (Detail)
40: R30 Commitments and Contingencies - Future Minimum HTML 35K
Rental Payments Required under Operating Leases
that have Initial or Remaining Non-Cancelable
Lease Terms in Excess of One Year (Detail)
41: R31 Subsequent Events - Additional Information HTML 28K
(Detail)
43: XML IDEA XML File -- Filing Summary XML 75K
42: EXCEL IDEA Workbook of Financial Reports XLSX 49K
5: EX-101.INS XBRL Instance -- onvo-20170630 XML 800K
7: EX-101.CAL XBRL Calculations -- onvo-20170630_cal XML 91K
8: EX-101.DEF XBRL Definitions -- onvo-20170630_def XML 321K
9: EX-101.LAB XBRL Labels -- onvo-20170630_lab XML 693K
10: EX-101.PRE XBRL Presentations -- onvo-20170630_pre XML 557K
6: EX-101.SCH XBRL Schema -- onvo-20170630 XSD 104K
44: ZIP XBRL Zipped Folder -- 0001564590-17-016946-xbrl Zip 86K
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Organovo Holdings, Inc. (the “Company”) for the period ended June 30, 2017, as filed with the Securities and Exchange Commission (the “Report”), I, Taylor Crouch, Chief Executive Officer and President and I, Craig Kussman, Chief Financial Officer of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
• |
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 9, 2017
|
/s/ Taylor Crouch |
|
Chief Executive Officer and President (Principal Executive Officer)
|
|
/s/ Craig Kussman |
|
Chief Financial Officer (Principal Financial Officer)
|
A signed original of this written statement required by Section 906 has been provided to Organovo Holdings, Inc. and will be retained by Organovo Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Organovo Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/9/17 | 8-K | ||
| For Period end: | 6/30/17 | |||
| List all Filings | ||||